Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Get alerts for new trials in your area by subscribing now
Multimodal Prehabilitation for Lung Cancer Surgery
for
Lung Cancer, Surgery
Location: Montreal
Sponsor: Stéphanie Chevalier
Sex: All
Age: 45+
Code: NCT05955248
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: Boston MA, New York NY, Montreal, Toronto,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06726148
Phase1, Phase2, Recruiting
Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL)
for
Diffuse Large B Cell Lymphoma (DLBCL)
Location: Montreal, Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06050694
Phase2, Recruiting
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
for
Major Neurocognitive Disorder
Location: Saint-Georges, Montreal
Sponsor: CHU de Quebec-Universite Laval
Sex: All
Age: 65+
Code: NCT04889794
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Transdiagnostic Internet Cognitive-behavior Therapy for Mixed Anxiety and Depressive Symptoms in Postnatal Women
for
Anxiety, Postnatal Depression
Location: Sherbrooke, Greenfield Park, Longueuil, Châteauguay
Sponsor: Université de Sherbrooke
Sex: Female
Age: 18+
Code: NCT06778096
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase3, Recruiting
Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
for
Asthma, Inflammation, Asthma in Children
Location: Sherbrooke
Sponsor: Université de Sherbrooke
Sex: All
Age: 6+
Code: NCT06981169
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Location: Halifax, Saint John, Boston MA, Providence RI,
Sponsor: University of British Columbia
Sex: All
Age: 0+
Code: NCT04634240
Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Boston MA, Providence RI, Lebanon NH, Quebec,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Kentville, Boston MA, Providence RI, Levis,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.